Differential effects of angiostatin, endostatin and interferon-α1 gene transfer on in vivo growth of human breast cancer cells
Open Access
- 18 June 2002
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 9 (13), 867-878
- https://doi.org/10.1038/sj.gt.3301703
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Endogenous angiogenesis inhibitors and their therapeutic implications.The International Journal of Biochemistry & Cell Biology, 2001
- Inhibition of Angiogenesis and Vascular Tumor Growth by Interferon-Producing Cells: A Gene Therapy ApproachThe American Journal of Pathology, 2000
- Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applicationsSeminars in Cancer Biology, 2000
- Gene therapy strategies for tumor antiangiogenesisJNCI Journal of the National Cancer Institute, 1998
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Angiostatin induces and sustains dormancy of human primary tumors in miceNature Medicine, 1996
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Cytokine therapeutics: lessons from interferonalpha.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Inhibition of Cell Motility by InterferonScience, 1980